Enfusion, Inc. (ENFN)
Apr 21, 2025 - ENFN was delisted (reason: acquired by CWAN)
10.76
0.00 (0.00%)
Inactive · Last trade price on Apr 17, 2025

Company Description

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.

It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services.

Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Enfusion, Inc.
Enfusion logo
CountryUnited States
Founded1998
IPO DateOct 21, 2021
IndustrySoftware - Application
SectorTechnology
Employees1,143
CEOOleg Movchan

Contact Details

Address:
125 South Clark Street, Suite 750
Chicago, Illinois 60603
United States
Phone312 253 9800
Websiteenfusion.com

Stock Details

Ticker SymbolENFN
ExchangeNYSE
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$17.00
CIK Code0001868912
CUSIP Number292812104
ISIN NumberUS2928121043
SIC Code7372

Key Executives

NamePosition
Oleg MovchanChief Executive Officer and Director
Bradley HerringChief Financial Officer
Neal PawarChief Operating Officer
Stephen MalherbeManaging Partner
Valeria GutowskiChief Accounting Officer
Daniel GromanChief Technology Officer
Matthew R. CampobassoGeneral Counsel and Corporate Secretary
Bronwen BastoneChief People Officer
Joseph DefeoGlobal Head of Managed Services Production
Jeff YoungHead of Implementation

Latest SEC Filings

DateTypeTitle
Apr 21, 2025SCHEDULE 13G/AFiling
Apr 21, 2025SCHEDULE 13G/AFiling
Apr 21, 2025SCHEDULE 13G/AFiling
Apr 21, 2025SCHEDULE 13G/AFiling
Apr 21, 2025POS AMPost-Effective amendments for registration statement
Apr 21, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 21, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 21, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 21, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Apr 21, 20258-KCurrent Report